Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03832283 · ClinicalTrials.gov registry record · NA

Patient Outcomes Reporting for Timely Assessments of Life With Depression: PORTAL-Depression

A NA study, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
4,161
Enrollment target

NCT03832283 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 4,161 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03832283, a NA study, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
4,161 participants
Enrollment target

Study Summary

Currently, very little research exists on whether patient portals could be used to integrate patient-reported outcome (PRO) measurement into the electronic health record (EHR) and clinical practice, even though 87% of ambulatory care practices have EHRs and 88% of U.S. adults have access to the internet. To date, no randomized controlled trial has examined whether patient portals can be used to collect PRO measures. The goal of this study is to implement the integration of a computerized adaptive test (CAT) for patient-reported outcome (PRO) measurement of depression symptoms into an electronic health record (EHR) and evaluate the effectiveness of collecting CAT PROs via an EHR patient portal in two randomized controlled trials. This study will advance the science of implementation of patient-centered outcomes research into clinical practice, as well as the evidence for high quality, accessible care.

Interventions

  • DIAGNOSTIC_TEST CAD-MDD/CAT-DI screening via MyChart
  • DIAGNOSTIC_TEST CAD-MDD/CAT-DI screening during clinic visit
  • OTHER CAT-DI monitoring via MyChart
  • OTHER PHQ-9 monitoring during clinic visits

Trial Details

FieldValue
Enrollment Target 4,161 participants
Start Date 2019-05-01
Est. Completion 2021-03-01
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT03832283

The ClinicalTrials.gov registry entry for NCT03832283 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4,161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which CAD-MDD/CAT-DI screening via MyChart is the first listed.

NCT03832283 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03832283 about?

NCT03832283 is a clinical study titled "Patient Outcomes Reporting for Timely Assessments of Life With Depression: PORTAL-Depression". Currently, very little research exists on whether patient portals could be used to integrate patient-reported outcome (PRO) measurement into the electronic health record (EHR) and clinical practice, even though 87% of ambulatory care practices have EHRs and 88% of U.S. adults have access to the inte...

What is the current status of trial NCT03832283?

This trial is currently completed. It is a NA study. The enrollment target is 4,161 participants. The study started on 2019-05-01. Estimated completion is 2021-03-01.

What interventions are being tested in trial NCT03832283?

The interventions under investigation include: CAD-MDD/CAT-DI screening via MyChart (DIAGNOSTIC_TEST), CAD-MDD/CAT-DI screening during clinic visit (DIAGNOSTIC_TEST), CAT-DI monitoring via MyChart (OTHER), PHQ-9 monitoring during clinic visits (OTHER).

Who is sponsoring clinical trial NCT03832283?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.